Stiehm E
Calif Med. 1971; 115(1):69.
PMID: 18730536
PMC: 1517915.
Singh S, Singh D, Baheti G, Karmarkar S
Pediatr Surg Int. 2003; 19(4):296-7.
PMID: 12682750
DOI: 10.1007/s00383-002-0853-9.
Bauer K, Kass B, Beeler D, Rosenberg R
J Clin Invest. 1984; 74(6):2033-41.
PMID: 6549015
PMC: 425392.
DOI: 10.1172/JCI111626.
Prentice C
J Clin Pathol Suppl (R Coll Pathol). 1980; 14:35-40.
PMID: 6159375
PMC: 1347103.
Ata M
Postgrad Med J. 1969; 45(523):319-22.
PMID: 5790930
PMC: 2466546.
DOI: 10.1136/pgmj.45.523.319.
Defibrination syndrome in phlegmasia ceruleaolens.
Saha G
Postgrad Med J. 1969; 45(519):48-9.
PMID: 5790922
PMC: 2466739.
Disseminated intravascular coagulation. Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation in children.
HITZIG W, STRAUB P, Lo S, FRICK P
Proc R Soc Med. 1968; 61(11 Part 1):1138.
PMID: 5722555
PMC: 1902887.
Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
Clarkson A, MACDONALD M, Petrie J, Cash J, Robson J
Br Med J. 1971; 3(5772):447-51.
PMID: 5567767
PMC: 1800376.
DOI: 10.1136/bmj.3.5772.447.
Haemostasis in fulminant hepatic failure.
FLUTE P
Br Med J. 1971; 1(5742):215-6.
PMID: 5541235
PMC: 1794824.
DOI: 10.1136/bmj.1.5742.215.
Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.
Das P
J Clin Pathol. 1970; 23(4):299-303.
PMID: 5464330
PMC: 476747.
DOI: 10.1136/jcp.23.4.299.
Defibrination syndrome due to scorpion venom poisoning.
Devi C, Reddy C, Devi S, Subrahmanyam Y, Bhatt H, Suvarnakumari G
Br Med J. 1970; 1(5692):345-7.
PMID: 5416814
PMC: 1698975.
DOI: 10.1136/bmj.1.5692.345.
Disseminated fibrin thromboembolism among neonates dying more than 48 hours after birth.
Boyd J
J Clin Pathol. 1969; 22(6):663-71.
PMID: 5365338
PMC: 474345.
DOI: 10.1136/jcp.22.6.663.
Acute promyelocytic leukemia with hypofibrinogenemia.
Laws W, BOHANNON R, Robinson A, AGGELER P
Calif Med. 1968; 109(3):219-23.
PMID: 5245524
PMC: 1503209.
Metabolism of fibrinogen in cirrhosis of the liver.
Tytgat G, Collen D, Verstraete M
J Clin Invest. 1971; 50(8):1690-701.
PMID: 5163179
PMC: 442069.
DOI: 10.1172/JCI106658.
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.
Ogston D, BENNETT N, OGSTON C
J Clin Pathol. 1971; 24(9):822-6.
PMID: 5139989
PMC: 477192.
DOI: 10.1136/jcp.24.9.822.
The intestine as a source of plasminogen activator activity.
Gans H, Mori K, Quinlan R, Richter D, Tan B
Ann Surg. 1971; 174(5):826-9.
PMID: 5113462
PMC: 1397566.
DOI: 10.1097/00000658-197111000-00013.
Experience with disseminated intravascular coagulation in a children's hospital.
Whaun J, Oski F, Urmson J
Can Med Assoc J. 1972; 107(10):963-7.
PMID: 5082021
PMC: 1941026.
Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease.
Briggs J, Prentice C, Hutton M, Kennedy A, McNicol G
Br Med J. 1972; 4(5832):82-5.
PMID: 5077472
PMC: 1786272.
DOI: 10.1136/bmj.4.5832.82.
The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis.
Katz J, Lurie A, Becker D, Metz J
J Clin Pathol. 1970; 23(6):529-32.
PMID: 4991001
PMC: 476824.
DOI: 10.1136/jcp.23.6.529.
Anticoagulant and thrombolytic drugs. II. Clinical aspects.
Ogston D, Douglas A
Drugs. 1971; 1(4):303-19.
PMID: 4939607
DOI: 10.2165/00003495-197101040-00003.
